indazoles has been researched along with Leucocythaemia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, A; Ajamie, RT; Carballares, S; Cronier, DM; de Dios, A; Donoho, GP; Du, J; Fales, KR; Foreman, RT; Gaynor, RB; Halstead, BW; Iversen, PW; Kreklau, EL; Lallena, MJ; Li, S; Lin, AB; Meier, TI; Qian, Y; Sissons, SE; Starling, JJ; Torrres, R; Wishart, GN; Wu, S; Ye, XS; Yin, T; Zeckner, D | 1 |
| Abe, A; Akinaga, S; Akiyama, T; Ishii, K; Ishikawa, Y; Kanda, Y; Kiyoi, H; Maeda, H; Minami, Y; Mori, Y; Naoe, T; Ozeki, K; Sato, Y; Shimizu, M; Shiotsu, Y; Tanizaki, R; Umehara, H | 1 |
| Albert, DH; Chen, CS; Goh, BC; Zhou, J | 1 |
| Kiyoi, H | 1 |
| Cao, J; He, Q; Hu, Y; Qian, S; Sun, M; Yan, Y; Yang, B; Zhu, H | 1 |
| Aller, P; Boyano-Adánez, Mdel C; Bréard, J; Calviño, E; de Blas, E; Estañ, MC; Sancho, P; Simón, GP | 1 |
| Appleton, DR; Berridge, MV; Copp, BR; Lambert, G; Page, MJ | 1 |
| Bouissane, L; El Kazzouli, S; Guillaumet, G; Khouili, M; Léonce, S; Pfeiffer, B; Rakib, EM | 1 |
| Chou, LC; Huang, LJ; Kuo, SC; Lee, FY; Teng, CM; Yang, JS | 1 |
| De Martino, C; Malorni, W; Marolla, A; Natali, PG; Nista, A; Salsano, F; Viora, M | 1 |
| Hiraoka, A; Kageyama, T; Kakishita, E; Masaoka, T; Matsuzawa, Y; Nagai, K; Okuda, K; Oshiba, S; Tatsumi, N; Uchino, H | 1 |
| Bruey, JM; Corcos, L; Garrido, C; Leroy, I; Lizard, G; Miguet, C; Plenchette, S; Rébé, C; Solary, E; Sordet, O | 1 |
2 review(s) available for indazoles and Leucocythaemia
| Article | Year |
|---|---|
ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Indazoles; Leukemia; Models, Biological; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases | 2009 |
[FLT3 kinase inhibitors for the treatment of acute leukemia].
Topics: Acute Disease; Clinical Trials as Topic; Drug Design; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Humans; Indazoles; Leukemia; Mutation; Piperazines; Quinazolines; Signal Transduction; Staurosporine | 2010 |
1 trial(s) available for indazoles and Leucocythaemia
| Article | Year |
|---|---|
[Granisetron oral phase III clinical trial--study on the inhibitory effect of granisetron for nausea/vomiting induced by chemotherapy for tumors in the hematopoietic organs].
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Granisetron; Hodgkin Disease; Humans; Indazoles; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Vomiting | 1993 |
9 other study(ies) available for indazoles and Leucocythaemia
| Article | Year |
|---|---|
A novel CDK9 inhibitor shows potent antitumor efficacy in preclinical hematologic tumor models.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase 9; Cyclohexylamines; Humans; Indazoles; Leukemia; Myeloid Cell Leukemia Sequence 1 Protein; Phosphorylation; Serine | 2014 |
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; fms-Like Tyrosine Kinase 3; Fusion Proteins, bcr-abl; HL-60 Cells; Humans; Indazoles; Isoleucine; K562 Cells; Leukemia; Male; Mice; Mice, Inbred C3H; Mice, SCID; Mutation, Missense; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcr; Threonine; Translocation, Genetic | 2009 |
SMT-A07, a 3-(Indol-2-yl) indazole derivative, induces apoptosis of leukemia cells in vitro.
Topics: Apoptosis; Benzamides; Caspases; Cell Line, Tumor; DNA Fragmentation; HL-60 Cells; Humans; Indazoles; Inhibitory Concentration 50; Leukemia | 2010 |
Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; Indazoles; Leukemia; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Oxides; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases | 2011 |
Kottamides A-D: novel bioactive imidazolone-containing alkaloids from the New Zealand ascidian Pycnoclavella kottae.
Topics: Alkaloids; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Bacillus subtilis; Candida albicans; Drug Screening Assays, Antitumor; Escherichia coli; Indazoles; Inhibitory Concentration 50; Leukemia; Leukemia P388; Mice; Molecular Structure; New Zealand; Nuclear Magnetic Resonance, Biomolecular; Stereoisomerism; Trichophyton; Tumor Cells, Cultured; Urochordata | 2002 |
Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors.
Topics: Animals; Cell Cycle; Cell Line, Tumor; Humans; Indazoles; Leukemia; Mice; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2006 |
Synthesis of furopyrazole analogs of 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1) as novel anti-leukemia agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Granulocytes; HL-60 Cells; Humans; Indazoles; Leukemia; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyrazoles | 2007 |
Inhibition of aerobic glycolysis in normal and neoplastic lymphoid cells induced by Lonidamine [1-(2,4-dichlorobenzyl)-I-H-indazol-3-carboxylic acid].
Topics: Aerobiosis; B-Lymphocytes; Dose-Response Relationship, Drug; Glycolysis; Humans; In Vitro Techniques; Indazoles; Lactates; Lactic Acid; Leukemia; Microscopy, Electron; Phenotype; Pyrazoles; T-Lymphocytes | 1984 |
Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cell Differentiation; Cell-Free System; Drug Resistance; Etoposide; Humans; Indazoles; Leukemia; Mitochondria; Oxides; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate; U937 Cells | 2001 |